Pelosi portfolio mention: Social media chatter has highlighted the inclusion of Tempus AI shares in prominent investor portfolios, drawing attention to its role in AI-driven healthcare applications.
Momentum from updates: Recent posts note upward price movement tied to a new CellCarta collaboration, publication of PRISM2 AI model data, and favorable Q2 earnings guidance that investors view as supportive of long-term growth in precision medicine.
AI drug discovery focus: Broader conversation positions the company alongside peers in AI-enabled drug discovery, with participants expressing optimism about scientific advancements and partnerships with major pharmaceutical and research institutions.
Note: This discussion summary was generated from an AI condensation of post data.
Tempus AI Insider Trading Activity
Tempus AI insiders have traded $TEM stock on the open market 72 times in the past 6 months. Of those trades, 0 have been purchases and 72 have been sales.
Here’s a breakdown of recent trading of $TEM stock by insiders over the last 6 months:
- ERIC P LEFKOFSKY (CEO and Chairman) has made 0 purchases and 44 sales selling 1,117,172 shares for an estimated $55,620,610.
- RYAN FUKUSHIMA (CEO, Data) has made 0 purchases and 13 sales selling 110,244 shares for an estimated $5,774,555.
- JAMES WILLIAM ROGERS (Chief Financial Officer) has made 0 purchases and 3 sales selling 32,466 shares for an estimated $1,707,846.
- ANDREW POLOVIN (EVP, Chief Legal Officer) has made 0 purchases and 4 sales selling 27,795 shares for an estimated $1,524,677.
- ERIK PHELPS (EVP, Chief Admin. Officer) has made 0 purchases and 2 sales selling 9,464 shares for an estimated $562,472.
- RYAN M BARTOLUCCI (Chief Accounting Officer) has made 0 purchases and 2 sales selling 7,018 shares for an estimated $352,755.
- JENNIFER A DOUDNA sold 2,673 shares for an estimated $147,015
- THOMAS EDWARD SCHOENHERR (CEO, Diagnostics) sold 1,580 shares for an estimated $69,630
- DAVID R EPSTEIN has made 0 purchases and 2 sales selling 620 shares for an estimated $28,408.
To track insider transactions, check out Quiver Quantitative's insider trading dashboard. You can access data on insider stock transactions through the Quiver Quantitative API insider transaction endpoint.
Tempus AI Revenue
Tempus AI had revenues of $382.5M in Q2 2026. This is an increase of 21.56% from the same period in the prior year.
You can track TEM financials on Quiver Quantitative's TEM stock page.
You can access data on TEM stock through the Quiver Quantitative API.
Tempus AI Hedge Fund Activity
We have seen 282 institutional investors add shares of Tempus AI stock to their portfolio, and 238 decrease their positions in their most recent quarter.
Here are some of the largest recent moves:
- JPMORGAN CHASE & CO added 4,989,062 shares (+inf%) to their portfolio in Q2 2026, for an estimated $289,016,361
- GC WEALTH MANAGEMENT RIA, LLC removed 4,199,843 shares (-63.5%) from their portfolio in Q2 2026, for an estimated $243,296,904
- GOLDMAN SACHS GROUP INC added 2,483,910 shares (+194.4%) to their portfolio in Q2 2026, for an estimated $143,892,906
- CITADEL ADVISORS LLC added 1,911,096 shares (+317.8%) to their portfolio in Q2 2026, for an estimated $110,709,791
- MORGAN STANLEY added 1,568,701 shares (+75.3%) to their portfolio in Q2 2026, for an estimated $90,874,848
- BANK OF AMERICA CORP /DE/ added 1,502,992 shares (+362.4%) to their portfolio in Q2 2026, for an estimated $87,068,326
- D. E. SHAW & CO., INC. removed 1,180,315 shares (-100.0%) from their portfolio in Q2 2026, for an estimated $68,375,647
To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard. You can access data on hedge funds moves and 13F filings through the Quiver Quantitative API 13F endpoint.
Tempus AI Government Contracts
We have seen $29,358,042 of award payments to $TEM over the last year.
Here are some of the awards which we have have seen pay out the most over the last year:
- ADAPT CRO SUPPORT SERVICES SOLICITATION: $12,741,975
To track government contracts to publicy traded companies, check out Quiver Quantitative's government contracts dashboard. You can access data on government contracts through the Quiver Quantitative API government contracts endpoint.
Tempus AI Price Targets
Multiple analysts have issued price targets for $TEM recently. We have seen 10 analysts offer price targets for $TEM in the last 6 months, with a median target of $66.0.
Here are some recent targets:
- Gene Mannheimer from Freedom Capital Markets set a target price of $59.0 on 07/01/2026
- Ryan MacDonald from Needham set a target price of $75.0 on 06/01/2026
- Mark Massaro from BTIG set a target price of $80.0 on 06/01/2026
- Yi Chen from HC Wainwright & Co. set a target price of $64.0 on 05/11/2026
- Dan Brennan from TD Cowen set a target price of $68.0 on 05/06/2026
- Tycho Peterson from Jefferies set a target price of $35.0 on 04/13/2026
- Subbu Nambi from Guggenheim set a target price of $60.0 on 03/30/2026
This article is not financial advice. See Quiver Quantitative's disclaimers for more information. Note that there may be inaccuracies due to mistakes in ticker-mapping, and other anomalies.
